Jiaoyang Liu1, Guoyan Tang1, He Huang2, Huan Li3, Peng Zhang3, Lihua Xu4,5. 1. Department of Hematology, The First Affiliated Hospital of Guangzhou Medical University, No. 1 Kangda Road, Guangzhou, 510230, Guangdong, China. 2. General Surgery Department, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. 3. Breast Cancer Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. 4. Department of Hematology, The First Affiliated Hospital of Guangzhou Medical University, No. 1 Kangda Road, Guangzhou, 510230, Guangdong, China. xlhua@gzhmu.edu.cn. 5. Guangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. xlhua@gzhmu.edu.cn.
Abstract
BACKGROUND: Nasopharyngeal carcinoma (NPC) is notable for its high incidence rates in select geographic and ethnic populations, especially among Chinese and Malay populations in Southeastern Asia. However, relevant biomarkers for the development and prognosis of NPC are not yet clear; therefore, discovering novel biomarkers will facilitate prediction of prognosis and development of targeted therapeutic tactics. This study aims to quest the potential prognostic value of NUAK1 (a downstream member of Akt) in NPC. METHODS: Immunohistochemistry was performed to measure the expression of NUAK1 in paraffin-embedded NPC samples. Statistical analysis, encompassing chi-square tests and Student's t test, was also employed to evaluate the association between the expression of NUAK1 and clinicopathologic features. In addition, the survival analysis was used to detect the prognostic significance of NUAK1 in NPC. RESULTS: Excessive expression of NUAK1 was found in NPC tissues at mRNA levels. Statistical analysis revealed a correlation of NUAK1 expression with maximum neck lymph node diameter (p = 0.025) and WHO histological type (p = 0.021). Furthermore, according to survival analysis, there was clinical relevance between the upregulation of NUAK1 in NPC and DFS. Subgroup analysis indicated that the expression of NUAK1 was strongly associated with DFS (p = 0.027) and OS (p = 0.026) duration in the patients of N1-3 tumors, but not in patients with N0 tumors. The expression of NUAK1 was also strongly associated with OS (p = 0.044) and DFS (p = 0.007) in patients of late stage tumour (UICC3-5), but not in patients of early stage tumour (UICC1-2). In addition, COX regression illustrated that N classification and NUAK1 expression were independent prognostic factors for disease-free survival. CONCLUSION: Our study postulated that NUAK1 is excessively expressed in NPC and may serve as a potential predictor of prognosis for NPC.
BACKGROUND:Nasopharyngeal carcinoma (NPC) is notable for its high incidence rates in select geographic and ethnic populations, especially among Chinese and Malay populations in Southeastern Asia. However, relevant biomarkers for the development and prognosis of NPC are not yet clear; therefore, discovering novel biomarkers will facilitate prediction of prognosis and development of targeted therapeutic tactics. This study aims to quest the potential prognostic value of NUAK1 (a downstream member of Akt) in NPC. METHODS: Immunohistochemistry was performed to measure the expression of NUAK1 in paraffin-embedded NPC samples. Statistical analysis, encompassing chi-square tests and Student's t test, was also employed to evaluate the association between the expression of NUAK1 and clinicopathologic features. In addition, the survival analysis was used to detect the prognostic significance of NUAK1 in NPC. RESULTS: Excessive expression of NUAK1 was found in NPC tissues at mRNA levels. Statistical analysis revealed a correlation of NUAK1 expression with maximum neck lymph node diameter (p = 0.025) and WHO histological type (p = 0.021). Furthermore, according to survival analysis, there was clinical relevance between the upregulation of NUAK1 in NPC and DFS. Subgroup analysis indicated that the expression of NUAK1 was strongly associated with DFS (p = 0.027) and OS (p = 0.026) duration in the patients of N1-3 tumors, but not in patients with N0 tumors. The expression of NUAK1 was also strongly associated with OS (p = 0.044) and DFS (p = 0.007) in patients of late stage tumour (UICC3-5), but not in patients of early stage tumour (UICC1-2). In addition, COX regression illustrated that N classification and NUAK1 expression were independent prognostic factors for disease-free survival. CONCLUSION: Our study postulated that NUAK1 is excessively expressed in NPC and may serve as a potential predictor of prognosis for NPC.
Authors: Markus Riester; Wei Wei; Levi Waldron; Aedin C Culhane; Lorenzo Trippa; Esther Oliva; Sung-Hoon Kim; Franziska Michor; Curtis Huttenhower; Giovanni Parmigiani; Michael J Birrer Journal: J Natl Cancer Inst Date: 2014-04-03 Impact factor: 13.506
Authors: Cristian A Lasagna-Reeves; Maria de Haro; Shuang Hao; Jeehye Park; Maxime W C Rousseaux; Ismael Al-Ramahi; Paymaan Jafar-Nejad; Luis Vilanova-Velez; Lauren See; Antonia De Maio; Larissa Nitschke; Zhenyu Wu; Juan C Troncoso; Thomas F Westbrook; Jianrong Tang; Juan Botas; Huda Y Zoghbi Journal: Neuron Date: 2016-10-06 Impact factor: 17.173
Authors: Francesca Maria Orlandella; Raffaela Mariarosaria Mariniello; Peppino Mirabelli; Anna Elisa De Stefano; Paola Lucia Chiara Iervolino; Vito Alessandro Lasorsa; Mario Capasso; Rosa Giannatiempo; Maria Rongo; Mariarosaria Incoronato; Francesco Messina; Marco Salvatore; Andrea Soricelli; Giuliana Salvatore Journal: Br J Cancer Date: 2020-05-18 Impact factor: 7.640